MoneyWorks4Me

Piramal Pharma submits analyst meet intimation

21 Feb 2024 Evaluate
Piramal Pharma has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst or Institutional Investor Meetings with the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1847.20
Dr. Reddys Labs. 1222.45
Cipla 1394.10
Lupin 2071.65
Zydus Lifesciences 1213.15
View more..